Paper41360809
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.
Pineda-Peña AC and 7 others. NPJ Vaccines, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms. Papers, record 41360809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41360809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References224
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36454813 | Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/36454813 | PubMed |
| 2 | 34525276 | SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34525276 | PubMed |
| 3 | 33027962 | Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33027962 | PubMed |
| 4 | 9651253 | Visualization of specific B and T lymphocyte interactions in the lymph node. | Science | 1998 | https://conductscience.org/library/papers/9651253 | PubMed |
| 5 | 37822054 | Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study. | J Med Virol | 2023 | https://conductscience.org/library/papers/37822054 | PubMed |
| 6 | 38141632 | Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. | Lancet Infect Dis | 2024 | https://conductscience.org/library/papers/38141632 | PubMed |
| 7 | 34648302 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. | Science | 2021 | https://conductscience.org/library/papers/34648302 | PubMed |
| 8 | 36131022 | Long-primed germinal centres with enduring affinity maturation and clonal migration. | Nature | 2022 | https://conductscience.org/library/papers/36131022 | PubMed |
| 9 | 36155617 | Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes. | JAMA | 2022 | https://conductscience.org/library/papers/36155617 | PubMed |
| 10 | 36259394 | Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2. | J Infect Dis | 2023 | https://conductscience.org/library/papers/36259394 | PubMed |
| 11 | 34706170 | Waning Immunity after the BNT162b2 Vaccine in Israel. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34706170 | PubMed |
| 12 | 35910658 | A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35910658 | PubMed |
| 13 | 30312894 | From zero to sixty and back to zero again: the metabolic life of B cells. | Curr Opin Immunol | 2019 | https://conductscience.org/library/papers/30312894 | PubMed |
| 14 | 29883414 | Immune History and Influenza Vaccine Effectiveness. | Vaccines (Basel) | 2018 | https://conductscience.org/library/papers/29883414 | PubMed |
| 15 | 34043894 | Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34043894 | PubMed |
| 16 | 38395697 | SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. | Immunity | 2024 | https://conductscience.org/library/papers/38395697 | PubMed |
| 17 | 32134478 | The Status of Vaccine Development Against the Human Cytomegalovirus. | J Infect Dis | 2020 | https://conductscience.org/library/papers/32134478 | PubMed |
| 18 | 31904601 | Toward precision adjuvants: optimizing science and safety. | Curr Opin Pediatr | 2020 | https://conductscience.org/library/papers/31904601 | PubMed |
| 19 | 37792377 | Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37792377 | PubMed |
| 20 | 36535326 | Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. | Nature | 2023 | https://conductscience.org/library/papers/36535326 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944129 | Recombinant B87 and HLJ0504 VP2 Vaccines Protect Chickens Against Infectious Bursal Disease. | Vet Sci | 2026 | https://conductscience.org/library/papers/42944129 | PubMed |
| 42931403 | Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931403 | PubMed |
| 42912726 | Immunoinformatics and reverse vaccinology design of self-amplifying RNA vaccine against marburg virus with structural dynamics and immune simulation analysis. | PLoS One | 2026 | https://conductscience.org/library/papers/42912726 | PubMed |
| 42826091 | Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42826091 | PubMed |
| 42653476 | ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653476 | PubMed |
| 42646726 | mRNA-1010 and the Future of Seasonal Influenza Prevention: Towards Next-Generation Respiratory Vaccination. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646726 | PubMed |
| 42488666 | Vaccination-enabled immune readiness for checkpoint blockade. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488666 | PubMed |
| 42457878 | Variant-specific and cross-reactive antibody responses following COVID-19 booster vaccinations and SARS-CoV-2 breakthrough infections. | Sci Rep | 2026 | https://conductscience.org/library/papers/42457878 | PubMed |
| 42439828 | Malaria serology for surveillance, insights into immunity, and vaccine development. | Infect Immun | 2026 | https://conductscience.org/library/papers/42439828 | PubMed |
| 42358960 | Soluble multi-epitope protein vaccination leverages antigen availability to drive CD8+ T cell immunity and tumor control. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358960 | PubMed |
| 42188814 | Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188814 | PubMed |
| 42188779 | Recombinant Immunogens Designed by AI Epitope Prioritization Confer Protection Against Mycobacterium tuberculosis. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188779 | PubMed |
| 42083894 | NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42083894 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41360809
GET https://conductscience.org/api/papers/v1/41360809/references?page=2